Bio-Techne (TECH) Q1 2023 Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH) Q1 2023 Earnings Conference Call November 1, 2022 9:00 AM ET

Company Participants

Chuck Kummeth - President, Chief Executive Officer

Jim Hippel - Executive Vice President, Chief Financial Officer

David Clair - Vice President, Investor Relations

Conference Call Participants

Puneet Souda - SVB Securities

Dan Arias - Stifel

Dan Leonard - Credit Suisse

Anna - Stephens

Alex Nowak - Craig Hallum

Catherine Schulte - Baird

Patrick Donnelly - Citi

Operator

Good morning and welcome to the Bio-Techne earnings conference call for the first quarter of fiscal year 2023.

At this time, all participants have been placed in listen-only mode. The call will be open for questions following management’s prepared remarks. During our Q&A session, please limit yourself to one question and a follow-up. If anyone should require Operator assistance during the conference, please press star, zero on your telephone keypad.

As a reminder, this conference is being recorded.

I would now like to turn the call over to David Clair, Bio-Techne’s Vice President, Investor Relations. Please go ahead, sir.

David Clair

Good morning and thank you for joining us. On the call with me this morning are Chuck Kummeth, Chief Executive Officer, and Jim Hippel, Chief Financial Officer of Bio-Techne.

Before we begin, let me briefly cover our Safe Harbor statement.

Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company’s future results as well as the potential impact of the COVID-19 pandemic on our operations and financial results. The company’s 10-K for fiscal year 2022 identifies certain factors that could cause the company’s actual results to differ materially from those projected in the forward-looking statements made during this call. The company does not undertake to update any forward-looking statements because of any new information or future events or developments. The 10-K as well as the company’s other SEC filings are available on the company’s website within its Investor Relations section.

During the call, non-GAAP financial measures may be used to provide information pertinent to ongoing business performance. Tables reconciling these measures to most comparable GAAP measures are available in the company’s press release issued earlier this morning on the Bio-Techne Corporation website at www.bio-techne.com.

Separately, we will be presenting at the Credit Suisse, Stifel, Stephens, and Evercore ISI healthcare conferences in November. We look forward to connecting with many of you at these upcoming conferences.